Publications

Assessing long-term effectiveness and cost-effectiveness of statin therapy in the UK: a modelling study using individual participant data sets.

Mihaylova B. et al, (2024), Health Technol Assess, 28, 1 - 134

Lifetime effects and cost-effectiveness of statin therapy for older people in the United Kingdom: a modelling study.

Mihaylova B. et al, (2024), Heart, 110, 1277 - 1285

Lifetime effects and cost-effectiveness of standard and higher-intensity statin therapy across population categories in the UK: a microsimulation modelling study.

Mihaylova B. et al, (2024), Lancet Reg Health Eur, 40

Estimating Costs Associated with Disease Model States Using Generalized Linear Models: A Tutorial.

Zhou J. et al, (2024), Pharmacoeconomics, 42, 261 - 273

Long-term cardiovascular risks and the impact of statin treatment on socioeconomic inequalities: a microsimulation model.

Wu R. et al, (2024), Br J Gen Pract, 74, e189 - e198

Impact of New Cardiovascular Events on Quality of Life and Hospital Costs in People With Cardiovascular Disease in the United Kingdom and United States.

Lui JNM. et al, (2023), J Am Heart Assoc, 12

Prediction Models for Individual-Level Healthcare Costs Associated with Cardiovascular Events in the UK.

Zhou J. et al, (2023), Pharmacoeconomics, 41, 547 - 559

Modelling decay in effectiveness for evaluation of behaviour change interventions: a tutorial for public health economists.

Candio P. et al, (2022), Eur J Health Econ, 23, 1151 - 1157

Estimating and Extrapolating Survival Using a State-Transition Modeling Approach: A Practical Application in Multiple Myeloma.

Majer I. et al, (2022), Value Health, 25, 595 - 604

Cost-effectiveness of statin therapy in categories of patients in the UK

Mihaylova B. et al, (2022), EUROPEAN HEART JOURNAL, 43, 2841 - 2841

CALIBRATING CARDIOVASCULAR DISEASE POLICY MODEL USING LARGE COHORT DATA

Wu R. et al, (2022), VALUE IN HEALTH, 25, S16 - S16

Impact of cardiovascular events on primary and hospital care costs: findings from UK Biobank study

Zhou J. et al, (2022), EUROPEAN HEART JOURNAL, 43, 2852 - 2852

Benefit accrual with cardiovascular disease prevention and effects of discontinuation: a modelling study

Wu R. et al, (2022), EUROPEAN HEART JOURNAL, 43, 2850 - 2850

EXCESS ANNUAL HOSPITAL COSTS DUE TO CARDIOVASCULAR EVENTS IN A CONTEMPORARY UK POPULATION TO INFORM HEALTH TECHNOLOGY ASSESSMENTS

Zhou J. et al, (2022), VALUE IN HEALTH, 25, S12 - S12

P70 Calibrating Cardiovascular Disease Policy Model Using Large Cohort Data

Wu R. et al, (2022), Value in Health, 25, S16 - S16

Search results (27)